Global Clinical Laboratory Testing Market Report: 2011 Edition

Clinical testing, which is a significant component of the global healthcare market, has been gaining further importance in the present global scenario. This has been mainly due to factors like consumer driven healthcare, aging demographics, expanded access to healthcare, and scientific advancements.

The major markets of clinical laboratory testing are the US, European nations and Australia. After facing a decline in 2009 due to extreme recessionary conditions, the US clinical laboratory testing market is expected to record a substantial growth in the coming years. Factors contributing to growth are growing aging population and increase in the number of accredited labs in the United States. The European clinical laboratory testing market is also witnessing growth due to increasing demand for laboratory medicine analysis in the region. The Australian market reported a decline in clinical pathology services in 2010 compared to 2009 due to reduced reimbursements by the Australian Federal government. However, increase in the establishment of new pathology collection centers and growing demand for diagnostic testing services from the ongoing aging population in the region, will drive the market.

An emerging and rapidly evolving system of healthcare, worldwide, has brought the issue of testing at the site of patient, to the forefront. The global Point-of-care testing market is expanding at a rapid rate, generating a whole set of new issues and challenges for the conventional laboratory testing systems.

Public and policy makers have come to realize that preventive measures for healthcare are as important as other healthcare measures thus leading to growth in demand for laboratory testing. Companion diagnostics has also taken roots constituting a trend in the present global perspective. In major parts of the world aging population is accelerating and people have taken to spending more on physicians and clinical services. These factors have put the clinical testing market on a growth chart, for many years to come. However, crunch in financial allocations for clinical diagnostic services is generally observed in many economies of the world, especially Europe where a funding pressure in clinical laboratory testing market is reported.

The leading players in the global clinical laboratory testing market are LabCorp, Quest Diagnostics, Sonic Healthcare and Healthscope Ltd. The market for clinical laboratory testing is intensely competitive with firms competing on the basis of accuracy and timeliness of results, among several other factors.

The report analyzes the global clinical laboratory testing market, with focus on the US, Europe and Australia. The growth drivers, trends and challenges are also discussed. The major regional players have been profiled, highlighting their strategies for this growing market.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests. SHOW LESS READ MORE >

1. Overview
1.1 Overview of laboratory Testing
1.2 Types of Clinical Laboratory Tests
1.3 Providers of Clinical Laboratory Tests

2. Market Overview
2.1 The United States
Market Size & Growth Rate
Share by Type of Labs
Healthcare Spending
CLIA Laboratories Statistics

2.2 European Market
2.2.1 Germany
2.2.2 Switzerland
2.2.3 The United Kingdom
2.2.4 Belgium
2.2.5 France
2.2.6 Italy
2.3 Australian Market
Overview
Pathology Benefits
Market Share

3. Point-of-Care Testing
Global Revenues
Breakdown by Region

4. Market Dynamics
4.1 Trends & Developments
4.1.1 Recognition of Value of Preventive Measures
4.1.2 Consolidation in the Pathology Services Sector
4.1.3 Companion Diagnostics

4.2 Growth Drivers
4.2.1 Growing and Aging Population
4.2.2 Increase in Personal Health Care Spending on Clinical Services
4.2.3 Increased Focus on Preventive Care

4.3 Challenges
4.3.1 Funding Pressure in Europe
4.3.2 Limited Resources and Lack of Awareness

5. Competitive Scenario
5.1 Competition in the Global market
5.2 Competition in the European Market
5.2.1 Germany
5.2.2 Switzerland
5.2.3 The UK

6. Company Profiles
6.1 Quest Diagnostics Incorporated
Company Overview
Key Financials
Business Strategies
Establishing Leadership in Medical Innovation
Expanding Geographic Reach

6.2 Laboratory Corporation of America Holdings
Company Overview
Key Financials
Business Strategies
Focus on Personalized Medicine
Expansion of Esoteric Testing Capabilities

6.3 Sonic Healthcare Limited
Company Overview
Key Financials
Business Strategies
International Diversification
Integration of Operational Divisions

6.4 Healthscope Ltd.
Company Overview
Key Financials
Business Strategies
Expanding Hospital Capacity
Market Expansion through Acquisitions

7. Market Outlook
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis

List of Charts:

Type of Clinical Laboratory tests
The US Clinical Laboratory Testing Market, 2004-2010
The US Diagnostics Testing Market Share by Labs, 2008
Average Length of Hospital Stays in the US, 1995-2009
The US Healthcare Spending (NHCE and PHCE), 2004-2014F
The US Personal Healthcare Expenditure Breakdown, 2009
The US CLIA Accredited Laboratories, 2004-2014F
Europe's Clinical Diagnostics Market, 2010
German Laboratory Market Structure, 2009
Swiss Pathology Market Structure, 2009
Share of Private and Public Labs in Total UK Pathology Market, 2009
The UK Public Pathology Market, 2006 & 2009
The Belgian Pathology Market, 2009
Pathology Services Provided in Australia, Nov 03-Nov 10
Pathology Benefits Paid in Australia, Nov 03-Nov 10
Share of Pathology Collections Centers in Australia, June 2010/December 2010
Worldwide POCT Market Revenues, 2009-2010
Worldwide Distribution of POCT Sales and Market Shares, 2009
Growth in Aging Population of the United States, 2004-2014F
Growth in PHCE on Physician and Clinical Services in the US,
Quest Diagnostics' Revenues by Business Segments, 2010
Quest Diagnostics' Revenues and Net Income, 2006-2010
LabCorp's Revenues by Business Segments, 2010
LabCorp's Revenues and Net Income, 2006-2010
Sonic Healthcare's Revenues by Business Segments, 2010
Sonic Healthcare's Revenues and Net Income, 2009-2010
Healthscope's Revenues by Business Segments, 2010
Healthscope's Revenues and Net Income, 2009-2010
US Clinical Laboratory Market Forecast, 2008-2014F

List of Tables:

CLIA Laboratories by Type of Facilities in the US, December 2010
European Diagnostic Testing Scenario
The French Pathology Market and Market Share of Top Players, 2009
The Italian Pathology Market and Market Share of Top Players, 2009
Change in Pathology Collection Centers in Australia, Jun 10-Dec10
Sites of POC Testing
The Largest Pathology Providers in Europe, 2009
The Leading Players of the German Pathology Market, 2009
The Leading Players of the Swiss Pathology Market, 2009
The Leading Players of the UK Pathology Market, 2009
Dependent & Independent Variables (2004– 2010)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

- Quest Diagnostics Incorporated

- Laboratory Corporation of America Holdings

- Sonic Healthcare Limited

- Healthscope Ltd